Is INVA stock safe? | Glauxie AI

Q: Is INVA stock safe?

Innoviva, Inc. (INVA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Pavel Raifeld. Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination... Employees: 159.

Q: What are the risks of investing in INVA?

Identify key risks of investing in INVA — debt, competition, volatility, and sector headwinds.

Q: Is INVA a good long-term investment?

Evaluate INVA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does INVA have?

Review INVA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is INVA stock safe?

🦉

Innoviva, Inc. (INVA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOPavel Raifeld

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate;...

Key Executives

Name	Title
David Altarac	Chief Medical Officer of IST
Marcie Cain	Chief People Officer
Marianne Zhen	Chief Accounting Officer & Secretary
Patricia Drake	Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.
Pavel Raifeld	Chief Executive Officer & Director
Stephen Basso	Chief Financial Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

INVA Profile Financials

What are the risks of investing in INVA? Is INVA a good long-term investment? How much debt does INVA have?